- Home
- ICLR vs GDEV Comparison
ICLR vs GDEV Comparison
Compare ICLR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- GDEV
- Stock Information
- Founded
- ICLR 1990
- GDEV 2009
- Country
- ICLR Ireland
- GDEV Cyprus
- Employees
- ICLR N/A
- GDEV N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- GDEV EDP Services
- Sector
- ICLR Health Care
- GDEV Technology
- Exchange
- ICLR Nasdaq
- GDEV Nasdaq
- Market Cap
- ICLR 11.5B
- GDEV N/A
- IPO Year
- ICLR 1998
- GDEV N/A
- Fundamental
- Price
- ICLR $133.96
- GDEV $15.89
- Analyst Decision
- ICLR Buy
- GDEV Buy
- Analyst Count
- ICLR 12
- GDEV 2
- Target Price
- ICLR $206.64
- GDEV $70.00
- AVG Volume (30 Days)
- ICLR 2.1M
- GDEV 37.0K
- Earning Date
- ICLR 04-30-2025
- GDEV 05-27-2025
- Dividend Yield
- ICLR N/A
- GDEV N/A
- EPS Growth
- ICLR 11.53
- GDEV N/A
- EPS
- ICLR 9.19
- GDEV 1.38
- Revenue
- ICLR $8,192,621,999.00
- GDEV $420,933,000.00
- Revenue This Year
- ICLR $1.63
- GDEV $4.73
- Revenue Next Year
- ICLR $4.82
- GDEV $16.15
- P/E Ratio
- ICLR $15.07
- GDEV $11.72
- Revenue Growth
- ICLR N/A
- GDEV N/A
- 52 Week Low
- ICLR $133.28
- GDEV $8.60
- 52 Week High
- ICLR $347.72
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- ICLR 33.96
- GDEV 63.60
- Support Level
- ICLR $135.00
- GDEV $15.00
- Resistance Level
- ICLR $141.96
- GDEV $18.33
- Average True Range (ATR)
- ICLR 6.69
- GDEV 1.40
- MACD
- ICLR 0.43
- GDEV 0.73
- Stochastic Oscillator
- ICLR 3.63
- GDEV 69.81
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.